Kiniksa Pharmaceuticals, Ltd.KNSANASDAQ
Loading
Stockholders Equity Over TimeExpanding
Percentile Rank100
3Y CAGR+12.7%
5Y CAGR+12.7%
Year-over-Year Change
Net worth of the company (assets minus liabilities)
3Y CAGR
+12.7%/yr
Annual compound
5Y CAGR
+12.7%/yr
Consistent
Percentile
P100
Near historical high
vs 5Y Ago
1.8x
Solid growth
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $567.61M | +29.5% |
| 2024 | $438.44M | -0.1% |
| 2023 | $438.84M | +10.8% |
| 2022 | $396.15M | +114.1% |
| 2021 | $185.04M | -40.7% |
| 2020 | $311.94M | +38.4% |
| 2019 | $225.42M | +216.1% |
| 2018 | $-194.22M | -116.5% |
| 2017 | $-89.71M | -248.6% |
| 2016 | $-25.73M | - |